Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4 + T cells depends on strength of the CD3 signal: Critical role for IL-2

Journal of Leukocyte Biology

Volumn 80, Issue 1, 2006, Pages 66-74

  Mukherjee, Sambuddho ^a   Ahmed, Asma ^a   Malu, Shruti ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Cell cycle progression; Costimulation; T cell activation

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL STIMULATION; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

CRICETULUS GRISEUS;

EID: 33751540126     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0505260     Document Type: Article

References (29)

1. Carreno, B. M., Collins, M. (2002) The B7 family of ligands and its receptors, new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20, 29-53.
2. Egen, J. G., Kuhns, M. S., Allison, J. P. (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3, 611-618.
3. Rudd, C. E., Schneider, H. (2003) Unifying concepts in CD28, ICOS and CTLA4 co-receptor signaling. Nat. Rev. Immunol. 3, 544-556.
4. Badou, A., Savignac, M., Moreau, M., Leclerc, C., Foucras, G., Cassar, G., Paulet, P., Lagrange, D., Druet, P., Guery, J. C., Pelletier, L. (2001) Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-γ production. Eur. J. Immunol. 31, 2487-2496.
5. Ise, W., Totsuka, M., Sogawa, Y., Ametani, A., Hachimura, S., Sato, T., Kumagai, Y., Habu, S., Kaminogawa, S. (2002) Naïve CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen. J. Immunol. 168, 3242-3250.
6. Schrum, A. G., Turka, L. A. (2002) The proliferative capacity of individual naïve CD4+ T cells is amplified by prolonged T cell antigen receptor triggering. J. Exp. Med. 196, 793-803.
7. Gett, A. V., Sallusto, F., Lanzavecchia, A., Geginat, J. (2003) T cell fitness determined by signal strength. Nat. Immunol. 4, 355-360.
8. Egen, J. G., Allison, J. P. (2002) Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35.
9. Krummel, M. F., Allison, J. P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
10. Chen, W., Jin, W., Wahl, S. M. (1998) Engagement of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) induces transforming growth factor β (TGFβ) production by murine CD4+ T cells. J. Exp. Med. 188, 1849-1857.
11. Sullivan, T. J., Letterio, J. J., van Elsas, A., Mamura, M., van Amelsfort, J., Sharpe, S., Metzler, B., Chambers, C. A., Allison, J. P. (2001) Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98, 2587-2592.
12. da Rocha Dias, S., Rudd, C. E. (2001) CTLA4 blockade of antigen induced cell death. Blood 97, 1134-1137.
13. Mukherjee, S., Maiti, P. K., Nandi, D. (2002) Role of CD80, CD86 and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell cycle progression and survival after activation with PMA and ionomycin. J. Leukoc. Biol. 72, 921-931.
14. Pandiyan, P., Gärtner, D., Soezeri, O., Radbruch, A., Schulze-Osthoff, K., Brunner-Weinzierl, M. C. (2004) CD152 (CTLA4) determines the unequal resistance of Th1 and Th2 cells against activation induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199, 831-842.
15. Doyle, A. M., Mullen, A. C., Villarino, A. V., Hutchins, A. S., High, F. A., Lee, H. W., Thompson, C. B., Reiner, S. (2001) Induction of CTLA4 restricts clonal expansion of helper T cells. J. Exp. Med. 194, 893-902.
16. Bergman, M. L., Cilio, C. M., Penha-Goncalves, C., Lamhamedi-Cherradi, S. E., Lofgren, A., Colucci, F., Lejon, K., Garchon, H. J., Holmberg, D. (2001) CTLA4-/- mice display T cell apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice. J. Autoimmun. 16, 105-113.
17. Anderson, D. E., Bieganowska, K. D., Bar-Or, A., Oliveira, E. M. L., Carreno, B., Collins, M., Hafler, D. A. (2000) Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat. Med. 6, 211-214.
18. Kuhns, M. S., Epshteyn, V., Sobel, R. A., Allison, J. P. (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc. Natl. Acad. Sci. USA 97, 12711-12716.
19. Madrenas, J., Chau, L. A., Teft, W. A., Wu, P. W., Jussif, J., Kasaian, M., Carreno, B. M., Ling, V. (2004) Conversion of CTLA4 from inhibitor to activator of T cells with a bispecific tandem single chain Fv ligand. J. Immunol. 172, 5948-5956.
20. Kwon, H., Jun, H-S., Khil, L-Y., Yoon, J-W. (2004) Role of CTLA4 in the activation of single and double positive thymocytes. J. Immunol. 173, 6645-6653.
21. Mukherjee, S., Ahmed, A., Nandi, D. (2005) CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A. J. Leukoc. Biol. 78, 144-157.
22. Höllsberg, P., Scholz, C., Anderson, D. E., Greenfield, E. A., Kuchroo, V. K., Freeman, G. J., Hafler, D. A. (1997) Expression of a hypoglycosylated form of CD86 (B7.2) on human T cells with altered binding properties to CD28 and CTLA4. J. Immunol. 159, 4799-4805.
23. Greenfield, E. A., Howard, E., Paradis, T., Nguyen, K., Benazzo, F., McLean, P., Höllsberg, P., Davis, G., Hafler, D. A., Sharpe, A. H., Freeman, G. J., Kuchroo, V. K. (1997) B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding. J. Immunol. 158, 2025-2034.
24. Freeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L-J., White, M., Fingeroth, J. D., Gribben, J. G., Nadler, L. M. (1991) Structure, expression and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174, 625-631.
25. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., Laszlo, G., et al. (1993) Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178, 2185-2192.
26. Wacholtz, M. C., Lipsky, P. E. (1993) Anti-CD3-stimulated Ca+2 signal in individual human peripheral T cells. J. Immunol. 150, 5338-5349.
27. Sprent, J. (1999) Stimulating naïve T cells. J. Immunol. 163, 4629-4636.
28. Lane, P., Gerhard, W., Hubele, S., Lanzavecchia, A., McConnell, F. (1993) Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. Immunology 80, 56-61.
29. Murtaza, A., Kuchroo, V. K., Freeman, G. J. (1999) Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int. Immunol. 11, 407-416.